NKO Partners has advised Dr Max on its acquisition of Zalfija.
Erdem & Erdem Advises Is Private Equity on Enlila Biotechnology Venture
Erdem & Erdem has advised Is Private Equity on the launch of Enlila.
Processing of Special Categories of Personal Data in the Pharmaceutical Industry: Analysis of the CJEU Ruling
The Court of Justice of the European Union (“CJEU”) has recently issued a significant judgment in the case “Lindenapotheke” (C-21/23), taking a clear stance on the processing of special categories of personal data, namely health data, in the context of online medicine sales within the pharmaceutical industry. The ruling sheds light on how the General Data Protection Regulation (“GDPR”) applies to the data that users provide when ordering pharmacy-only medicinal products online, even those not subject to prescription, and provides clear guidance on the rights and obligations of data controllers.
Inside Insight: Interview with Mihaela Scarlatescu of Farmexim
Farmexim Head of Legal and Compliance Director Mihaela Scarlatescu discusses her 25-year legal journey, leading in-house strategy across pharma and retail, and balancing legal precision with business impact.
Schoenherr and Savoric & Partners Advise on Accession Capital Partners' EUR 30 Million Growth Investment into Vetti Group
Schoenherr has advised Accession Capital Partners on its EUR 30 million growth capital investment into Vetti Group. Savoric & Partners advised Vetti Group.
KSB Advises on mcePharma Sale to Brenntag Group
Kocian Solc Balastik has advised Ivan Mikes on the sale of mcePharma to the Brenntag Group. Pierstone reportedly advised Brenntag.
Gessel Advises ArKa Foundation on Sale of Med-Gastr to Tar Heel Capital
Gessel has advised the ArKa family foundation on the sale of a 75% stake in Centrum Medyczne Med-Gastr to Tar Heel Capital. Sobczynscy i Partnerzy reportedly advised Tar Heel Capital.